Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control – a scoping review and perspective

Like in other infectious diseases, war significantly alters DR-TB dynamics in affected countries and bordering or refugee-hosting countries, threatening progress towards TB elimination and exacerbating the global antimicrobial resistance crisis. While innovations have improved the feasibility of DR-TB care in CE, access remains severely constrained. Identified risk factors, challenges and priorities underscore the need for expanded TB support and targeted research, particularly for vulnerable populations in CE scenarios.

Authors

Institutions

Publication Details

Journal
BMJ Global Health
Published
2026-02-01
DOI
https://doi.org/10.1136/bmjgh-2025-019011
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control – a scoping review and perspective

Irina Felker, Ignacio Monedero-Recuero, Mary Rosary T. Santiago, Xiangxu Wei et al.
BMJ Global Health
Tuberculosis Research and Epidemiology
article

Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control – a scoping review and perspective

Irina Felker, Ignacio Monedero-Recuero, Mary Rosary T. Santiago, Xiangxu Wei, Fabienne Jouberton, Paul Daru, Mariama Mahmoud, Afshan K. Isani, Alena Skrahina, Adekola Oyedokun Adekunle, María Rodríguez-Ortega, Hoang Thi Thanh Thuy, Chen-Yuan Chiang, Sha Wei, Raquel Duarte, Hamdan Mustafa Hamdan
article en

Abstract

Like in other infectious diseases, war significantly alters DR-TB dynamics in affected countries and bordering or refugee-hosting countries, threatening progress towards TB elimination and exacerbating the global antimicrobial resistance crisis. While innovations have improved the feasibility of DR-TB care in CE, access remains severely constrained. Identified risk factors, challenges and priorities underscore the need for expanded TB support and targeted research, particularly for vulnerable populations in CE scenarios.

BMJ Global HealthVol. 11(2)
Family Health International 360 (US), Department of Health (PH), Pakistan Institute of Engineering and Applied Sciences (PK), Universidade do Porto (PT), University of Toronto (CA), University of the Witwatersrand (ZA), National Ribat University (SD), National Centre for Research (Sudan) (SD), LRS Institute of Tuberculosis and Respiratory Diseases (IN), Novosibirsk Tuberculosis Research Institute (RU), Republican Scientific and Practical Centre of Pulmonology and Tuberculosis (BY), Institute of Human Virology (NG), International Union Against Tuberculosis and Lung Disease (FR), Public Health Ontario (CA), Shanghai Pulmonary Hospital (CN), Ministry of Health (MN), Instituto de Saúde (BR), National Institute of Health Dr. Ricardo Jorge (PT), Wan Fang Hospital (TW), Ministry of Health (BB), Hanoi Lung Hospital (VN), Médecins Sans Frontières (FR), Taipei Medical University (TW), Universidad Pontificia Comillas (ES)
Tongji University, Action Damien, Shanghai Pulmonary Hospital
Openalex Percentile: Top 48%
Tuberculosis Research and Epidemiology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.